Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Sivova, Nadia ^a   Launay, David ^a   Wémeau Stervinou, Lidwine ^a   De Groote, Pascal ^a   Remy Jardin, Martine ^a   Denis, Guillaume ^a   Lambert, Marc ^a   Lamblin, Nicolas ^a   Morell Dubois, Sandrine ^a   Fertin, Marie ^a   Lefevre, Guillaume ^a   Sobanski, Vincent ^a   Le Rouzic, Olivier ^a   Hatron, Pierre Yves ^a   Wallaert, Benoit ^a   Hachulla, Eric ^a   Perez, Thierry ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NITRIC OXIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION CAPACITY OF THE LUNGS FOR CARBON MONOXIDE; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG BLOOD VOLUME; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MEMBRANE CONDUCTANCE; PATIENT CARE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; CARBON MONOXIDE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 84885771799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078001     Document Type: Article

References (32)

1. Hachulla E, Launay D, (2011) Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 40: 78-83. doi:10.1007/s12016-010-8198-y. PubMed: 20143182.
2. Le Pavec J, Launay D, Mathai SC, Hassoun PM, Humbert M, (2011) Scleroderma Lung Disease. Clin Rev Allergy Immunol 40: 104-116. doi:10.1007/s12016-009-8194-2. PubMed: 20063208.
3. Launay D, Mouthon L, Hachulla E, Pagnoux C, de Groote P, et al. (2007) Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 34: 1005-1011. PubMed: 17444586.
4. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, et al. (2009) Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 60: 569-577. doi:10.1002/art.24267. PubMed: 19180517.
5. Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, et al. (2006) Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 54: 184-191. doi:10.1002/art.21538. PubMed: 16385514.
6. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, et al. (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179: 151-157. doi:10.1164/rccm.200806-953OC. PubMed: 18931333.
7. Chang B, Wigley FM, White B, Wise RA, (2003) Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 30: 2398-2405. PubMed: 14677184.
8. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34: 1219-1263. doi:10.1183/09031936.00139009. PubMed: 19749199.
9. Launay D, Sitbon O, Cordier JF, Hachulla E, Mouthon L, et al. (2012) (in press)) Survival and prognostic factors in patients with incident and newly diagnosed SSc-associated pulmonary arterial hypertension from the French Registry. Ann Rheum Dis.
10. Lefèvre G, Dauchet L, Hachulla E, Montani D, Sobanski V, et al. (2013) (in press)) Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: A systematic review and meta-analysis. Arthritis Rheum.
11. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, et al. (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52: 3792-3800. doi:10.1002/art.21433. PubMed: 16320330.
12. Plummer AL, (2008) The carbon monoxide diffusing capacity: clinical implications, coding, and documentation. Chest 134: 663-667. doi:10.1378/chest.07-1771. PubMed: 18583519.
13. Sun XG, Hansen JE, Oudiz RJ, Wasserman K, (2003) Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 41: 1028-1035. doi:10.1016/S0735-1097(02)02964-9. PubMed: 12651053.
14. Steen V, Medsger TA Jr., (2003) Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 48: 516-522. doi:10.1002/art.10775. PubMed: 12571862.
15. Roughton FJ, Forster RE, (1957) Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol 11: 290-302. PubMed: 13475180.
16. Degano B, Mittaine M, Guénard H, Rami J, Garcia G, et al. (2009) Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. J Appl Physiol 107: 139-143. doi:10.1152/japplphysiol.91621.2008. PubMed: 19423834.
17. Guenard H, Varene N, Vaida P, (1987) Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. Respir Physiol 70: 113-120. doi:10.1016/S0034-5687(87)80036-1. PubMed: 3659606.
18. Pernot J, Puzenat E, Magy-Bertrand N, Manzoni P, Gondouin A, et al. (2012) Detection of Interstitial Lung Disease in Systemic Sclerosis through Partitioning of Lung Transfer for Carbon Monoxide. Respir; Int Rev Thorac Dis, 84: 461-8. PubMed: 22301769.
19. Overbeek MJ, Groepenhoff H, Voskuyl AE, Smit EF, Peeters JW, et al. (2008) Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study. Respir Res 9: 68. doi:10.1186/1465-9921-9-68. PubMed: 18828919.
20. LeRoy EC, Medsger TA Jr., (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28: 1573-1576. PubMed: 11469464.
21. (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590. doi:10.1002/art.1780230510. PubMed: 7378088.
22. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, et al. (2005) Standardisation of the measurement of lung volumes. Eur Respir J Off J Eur Soc Clinical Respir Physiology 26: 511-522. PubMed: 16135736.
23. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, et al. (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J Off J Eur Soc Clinical Respir Physiology 26: 720-735. PubMed: 16204605.
24. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS Statement: guidelines for the six-minute walk test Am J Respir Crit Care Med 166: 111-117 doi:10.1164/ajrccm.166.1.at1102. PubMed: 12091180.
25. Aguilaniu B, Maitre J, Glénet S, Gegout-Petit A, Guénard H, (2008) European reference equations for CO and NO lung transfer. Eur Respir J Off J Eur Soc Clinical Respir Physiology 31: 1091-1097. PubMed: 18216061.
26. Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, et al. (2004) CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 232: 560-567. doi:10.1148/radiol.2322031223. PubMed: 15286324.
27. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, et al. (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177: 1248-1254. doi:10.1164/rccm.200706-877OC. PubMed: 18369202.
28. Pande JN, Gupta SP, Guleria JS, (1975) Clinical significance of the measurement of membrane diffusing capacity and pulmonary cappillary blood volume. Respir; Int Rev Thorac Dis 32: 317-324. PubMed: 1166137.
29. Agustí AG, Roca J, Gea J, Wagner PD, Xaubet A, et al. (1991) Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis 143: 219-225. doi:10.1164/ajrccm/143.2.219. PubMed: 1990931.
30. Wémeau-Stervinou L, Perez T, Murphy C, Polge AS, Wallaert B, (2012) Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. Respir Med 106: 564-570. doi:10.1016/j.rmed.2011.12.011. PubMed: 22221584.
31. Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, et al. (2003) Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 167: 438-443. doi:10.1164/rccm.200202-135OC. PubMed: 12406847.
32. Launay D, Remy-Jardin M, Michon-Pasturel U, Mastora I, Hachulla E, et al. (2006) High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 33: 1789-1801. PubMed: 16960939.